Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novo Nordisk A/S ADR buy Nordea Equity Research

Start price
€39.32
15:15 / 50%
Target price
-
19.06.27
Performance (%)
-0.81%
Price
€39.00
20:53
Summary
This prediction is currently active. Since the start of the prediction for Novo Nordisk A/S ADR the price has only changed by -0.81%. This prediction currently runs until 19.06.27. The prediction end date can be changed by Nordea_Equity_Resear at any time. Nordea_Equity_Resear has 50% into this prediction
Performance without dividends (%)
Name 1w
Novo Nordisk A/S ADR -0.81%
iShares Core DAX® 1.750%
iShares Nasdaq 100 4.301%
iShares Nikkei 225® 9.895%
iShares S&P 500 2.542%

Comments by Nordea_Equity_Resear for this prediction

In the thread Novo Nordisk A/S ADR diskutieren

Novo Nordisk A/S (NVO) was upgraded by Nordea Equity Research from "hold" to "buy".
Ratings data for NVO provided by MarketBeat